| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |